Annual General Meeting 2022

Remedy Entertainment Plc’s Annual General Meeting 2022 was held on Wednesday April 13, 2022 at 10:00 a.m. (EEST).

Remedy’s Board of Directors resolved on extraordinary meeting procedures pursuant to temporary legislation (375/2021). Remedy’s shareholders and their proxy representatives were able only participate in the meeting and exercise their shareholder rights by voting in advance as well as by submitting counterproposals and asking questions in advance. It was not possible to attend the meeting in person at the meeting venue.

A pre-recorded speech by Remedy’s Chairman and CEO was published prior to the Annual General Meeting on April 13, 2022 at this website. The meeting was not livestreamed.

The video presentation of Remedy’s Chairman Markus Mäki and CEO Tero Virtala

Important dates

March 22, 2022	Annual General Meeting notice is published
March 22, 2022	The Financial Statements, the Board of Directors’ report and the Auditor’s Report are available on this website
March 28, 2022 at 12 noon	Counterproposals by shareholders to be submitted at the latest
March 29, 2022	Potential counterproposals are published
March 29, 2022 at 12 noon	Registration and advance voting begins. Electronic registration link is added to this website. Power of attorney template and voting form are published
March 30, 2022 at 4 pm	Questions by shareholders to be submitted at the latest
April 1, 2022	Annual General Meeting record date
April 4, 2022	Questions by shareholders, management’s written responses and other counterproposals than those put up to a vote are published at the latest
April 7, 2022 at 4 pm	Registration and advance voting period ends
April 8, 2022 by 10 am	Nominee-registered shareholders must be temporarily registered into Remedy’s shareholders’ register at the latest
April 13, 2022 at 10 am start	Annual General Meeting date. Chairman’s and CEO’s speeches are published on this website prior to the start of the meeting

Further instructions can be found in the Annual General Meeting notice below.

Questions by shareholders and management’s responses

No shareholder questions where received by the deadline.

Counterproposals to the General Meeting

No counterproposals where received by the deadline.